Salus Reports Earnings Results for the Nine Months Ended September 2019; Provides Guidance for the Year 2020
December 22, 2019
Share
Salus reported earnings results for the nine months ended September 2019. For the period, the company net profit rose by an annual 38% to EUR 5.4 million as net sales increased by more than 35% to EUR 255 million. Operating profit increased by 62% on the year to EUR 5.9 million.
The company provided guidance for the year 2020. For the year, the company plans to post a EUR 5.7 million net profit in 2020 on the back of EUR 350 million in net sales revenue. Operating profit is expected to be EUR 7.3 million.
Salus Ljubljana dd is a Slovenia-based company engaged in the wholesale and distribution of medical products. The Companyâs portfolio includes pharmaceuticals, medical devices, medical supplies, food supplements, cosmetic products and other health products. The Company's core clients are pharmacies, hospitals and health centers from both Slovenia and abroad. Moreover, Salus Ljubljana dd offers the products to its business partners through the Internet store. The Company also provides additional services related to the registration of medicines and the distribution and storage of pharmaceuticals and other medical products.
SALUS, LJUBLJANA, D. D. 
